الكشف عن بعض عوامل الضراوة بين المبيضات المعزولة من المرضى وانتشار جين candidalysin ECE1

Mora C, Tittensor DP, Adl S, Simpson AG, Worm B. How many species are there on Earth and in the ocean?. PLoS Biol. 2011; 9 (8): e1001127. https://doi.org/10.1371/journal.pbio.1001127.

Gnat S, Łagowski D, Nowakiewicz A, Dyląg M. A global view on fungal infections in humans and animals: opportunistic infections and microsporidioses. J Appl Microbiol. 2021 1; 131(5): 2095-113. https://doi.org/10.1111/jam.15032

Naglik JR, Gaffen SL, Hube B. Candidalysin: discovery and function in Candida albicans infections. Curr Opin Microbiol. 2019; 52: 100-109. https://doi.org/10.1016/j.mib.2019.06.002

Hibbett DS, Blackwell M, James TY, Spatafora JW, Taylor JW, Vilgalys R. Phylogenetic taxon definitions for Fungi, Dikarya, Ascomycota and Basidiomycota. IMA Fungus. 2018; 9: 291-298 https://doi.org/10.5598/imafungus.2018.09.02.05.

Russell CM, Schaefer KG, Dixson A, Gray ALH, Pyron RJ, Alves DS, et al. The Candida albicans virulence factor candidalysin polymerizes in solution to form membrane pores and damage epithelial cells. Elife. 2022; 29: 11: e75490. https://doi.org/10.7554/eLife.75490

Richardson JP, Brown R, Kichik N, Lee S, Priest E, Mogavero S, et al. Candidalysins Are a New Family of Cytolytic Fungal Peptide Toxins. ASM JmBio. 2022 Feb 22; 13(1): e0351021. https://doi.org/10.1128/mbio.03510-21

Chen H, Zhou X, Ren B, Cheng L. The regulation of hyphae growth in Candida albicans. Virulence. 2020; 11(1): 337-348. https://doi.org/10.1080/21505594.2020.1748930

Mogavero S, Sauer FM, Brunke S, Allert S, Schulz D, Wisgottet S, et al. Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by Candida albicans. Cell Microbiol. 2021; 23(10): e13378. https://doi.org/10.1111/cmi.13378

Vaňková E, Kašparová P, Dulíčková N, Čeřovský V. Combined effect of lasioglossin LL-III derivative with azoles against Candida albicans virulence factors: biofilm formation, phospholipases, proteases and hemolytic activity. FEMS Yeast Res. 2020 1; 20(3): foaa020. https://doi.org/10.1093/femsyr/foaa020

Aldossary MA, Almansour NA, Abdulraheem BS. Isolation and identification of Candida species from the oral cavity of cancer patients undergoing chemotherapy in Basrah, Iraq. Biol Agr Healthc. 2016; 6(18): 22-30.

Elmer W K, Stephen D A, William M J. Laboratory approach to the diagnosis of fungal infections.1992. 14th edition, J P Lipincott Company, Philadelphia. pp. 387-840.

Wayne PA. Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: 27th ed informational supplement. CLSI document M100-S20. PA 2017.

Deravi N, Fathi M, Tabatabaeifar SN, Ahmadi B, Shokoohi G, Ansari S. Azole antifungal resistance in Candida albicans and Candida glabrata isolated from vulvovaginal candidiasis patients. Arch Clin Infect Dis. 2021; 16(2). https://dx.doi.org/10.5812/archcid.106360

Shoukat M, Ullah F, Tariq MN, Din G, Khadija B, Faryal R. Profiling of potential pathogenic Candida species in obesity. Microb Pathog. 2023; 174: 105894. https://dx.doi.org/10.1016/j.micpath.2022.105894

Staib F. Serum-proteins as nitrogen source for yeastlike fungi. Sabouraudia. 1965; 4(3): 187-93. https://doi.org/10.1080/00362176685190421

Swidergall M, Solis NV, Millet N, Huang MY, Lin J, Lin J, et al. Activation of EphA2-EGFR signaling in oral epithelial cells by Candida albicans virulence factors. PLoS Pathog. 2021; 20: 17(1): e1009221. https://doi.org/10.1371/journal.ppat.1009221

Jin Y, Yip HK, Samaranayake YH, Yau JY, Samaranayake LP. Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol. 2003; 41(7): 2961-7. https://doi.org/10.1128/jcm.41.7.2961-2967.2003

Davarzani F, Saidi N, Besharati S, Saderi H, Rasooli I, Owlia P. Evaluation of Antibiotic Resistance Pattern, Alginate and Biofilm Production in Clinical Isolates of Pseudomonas aeruginosa. Iran J Public Health. 2021; 50(2): 341-349. https://doi.org/10.18502/ijph.v50i2.5349

Daniel W W, Cross C L. Biostatistics: A Foundation for Analysis in the Health Sciences. 11th Edition, John Wiley & Sons, Hoboken. 2018. 720 pp.

Sardi JCO, Scorzoni L, Bernardi T, Fusco-Almeida AM, Mendes Giannini MJS. Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol. 2013; 62(Pt1): 10-24. https://doi.org/10.1099/jmm.0.045054-0

Pinto-Almazán R, Frías-De-León MG, Fuentes-Venado CE, Arenas R, González-Gutiérrez L, Chávez-Gutiérrez E, et al. Frequency of Candida spp. in the Oral Cavity of Asymptomatic Preschool Mexican Children and Its Association with Nutritional Status. Children (Basel). 2022; 9(10): 1510. https://doi.org/10.3390/children9101510

Taverne-Ghadwal L, Kuhns M, Buhl T, Schulze MH, Mbaitolum WJ, Kersch L, et al. Epidemiology and prevalence of Oral candidiasis in HIV patients from Chad in the post-HAART era. Front Microbiol. 2022; 13. https://doi.org/10.3389/fmicb.2022.844069

Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA. Oral candidiasis: a disease of opportunity. J Fungi. 2020; 6(1): 15. https://doi.org/10.3390/jof6010015

Patil S, Rao RS, Majumdar B, Anil S. Clinical Appearance of Oral Candida Infection and Therapeutic Strategies. Front Microbiol. 2015; 6: 1391. https://doi.org/10.3389/fmicb.2015.01391

Habib KA, Najee EN, Abood MS. Identification of Candida species Isolated From Vulvovaginal Candidiasis Patients by Chromgen agar and PCR-RFLP Method. Baghdad Sci J. 2016; 13(2): 291-297. https://doi.org/10.21123/bsj.2016.13.2.0291

Mulet Bayona JV, Salvador García C, Tormo Palop N, Valentín Martín A, González Padrón C, Colomina Rodríguez J, et al. Novel Chromogenic Medium CHROMagarTM Candida Plus for Detection of Candida auris and Other Candida Species from Surveillance and Environmental Samples: A Multicenter Study. J Fungi (Basel). 2022; 8(3): 281. https://doi.org/10.3390/jof8030281

Patel M. Oral Cavity and Candida albicans: Colonisation to the Development of Infection. Pathogens. 2022; 11(3): 335. https://doi.org/10.3390/pathogens11030335

Quinn PJ, Markey BK, Leonard FC, Hartigan P, Fanning S, Fitzpatrick E. Veterinary microbiology and microbial disease. 2nd edition. Wiley-Blackwell, 2011, Chichester, West Sussex, UK.

Chaffin WL, López-Ribot JL, Casanova M, Gozalbo D, Martínez JP. Cell wall and Secreted proteins of Candida albicans: identification, function, and expression. Microbiol Mol Biol Rev. 1998; 62(1):130-80. https://doi.org/10.1128/MMBR.62.1.130-180.1998

Wang X, Mohammad IS, Fan L, Zhao Z, Nurunnabi M, Sallam MA, et al. Delivery strategies of amphotericin B for invasive fungal infections. Acta Pharmaceutica Sinica B. 2021; 11(8): 2585-604. https://doi.org/10.1016/j.apsb.2021.04.010

Mohamed BJ and AL. Thwani A. The susceptibility test of vaginal yeasts and their relationship with the age in Iraqi women. Baghdad Sci J. 2010; 7(3): 1174-1180. https://doi.org/10.21123/bsj.2010.7.3.1174-1180

Bilal H, Hou B, Shafiq M, Chen X, Shahid MA, Zeng Y. Antifungal susceptibility pattern of Candida isolated from cutaneous candidiasis patients in eastern Guangdong region: A retrospective study of the past 10 years. Front Microbiol. 2022; 13: 981181. https://doi.org/10.3389/fmicb.2022.981181

Wang E, Farmakiotis D, Yang D, McCue DA, Kantarjian HM, Kontoyiannis DP, et al. The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality. J Antimicrob Chemother. 2015; 70(8): 2362-8. https://doi.org/10.1093/jac/dkv087

Al-Dahlaki NOM, and Al-Qaysi SAS. Production and Identification of Secondary Metabolite Gliotoxin-Like Substance Using Clinical Isolates of Candida spp. Microbiol Biotechnol Lett. 2022; 50(4): 488-500. https://doi.org/10.48022/mbl.2209.09007

Magaldi S, Mata-Essayag S, Hartung de Capriles C, Perez C, Colella MT, Olaizola C. Well diffusion for antifungal susceptibility testing. Int J Infect Dis. 2004; 8(1): 39-45. https://doi.org/10.1016/j.ijid.2003.03.002

Yasu T, Konuma T, Kuroda S, Takahashi S, Tojo A. Effect of Cumulative Intravenous Voriconazole Dose on Renal Function in Hematological Patients. Antimicrob Agents Ch. 2018; 62(9): e00507-18. https://doi.org/10.1128/aac.00507-18

Jenks JD, Salzer HJ, Prattes J, Krause R, Buchheidt D, Hoenigl M. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy. Drug Des Devel Ther. 2018; 12: 1033-1044. https://doi.org/10.2147/dddt.s145545

Othman KI, Abdullah SM, Majid AM. Isolation and Identification Candida spp. from Urine and Antifungal Susceptibility Test. Iraqi J Sci. 2018; 59(4B): 1981-1988. http://doi.org/10.24996/ijs.2018.59.4B.3

Vadiraj S, Nayak R, Choudhary GK, Kudyar N, Spoorthi BR. Periodontal pathogens and respiratory diseases- evaluating their potential association: a clinical and microbiological study. J Contemp Dent Pract. 2013; 14(4): 610-5. https://doi.org/10.5005/jp-journals-10024-1373

Di Cosola M, Cazzolla AP, Charitos IA, Ballini A, Inchingolo F, Santacroce L. Candida albicans and oral carcinogenesis. A brief review. J Fungi. 2021; 7(6): 476. https://doi.org/10.3390/jof7060476

Cangui-Panchi SP, Ñacato-Toapanta AL, Enríquez-Martínez LJ, Reyes J, Garzon-Chavez D, Machado A. Biofilm-forming microorganisms causing hospital-acquired infections from intravenous catheter: A systematic review. Curr Res Microb Sci. 2022; 3: 100175. https://doi.org/10.1016/j.crmicr.2022.100175

Bekkal Brikci Benhabib O, Boucherit-Otmani Z, Boucherit K, Djediat C. Interaction in a dual-species biofilm of Candida albicans and Candida glabrata co-isolated from intravascular catheter. Microb Pathog. 2021; 152: 104613. https://doi.org/10.1016/j.micpath.2020.104613

Lohse MB, Gulati M, Johnson AD, Nobile CJ. Development and regulation of single- and multi-species Candida albicans biofilms. Nat Rev Microbiol. 2018; 16(1): 19-31. https://doi.org/10.1038/nrmicro.2017.107

Rodríguez-Cerdeira C, Martínez-Herrera E, Carnero-Gregorio M, López-Barcenas A, Fabbrocini G, Fida M, El-Samahy M, et al. Pathogenesis and Clinical Relevance of Candida Biofilms in Vulvovaginal Candidiasis. Front Microbiol. 2020; 11: 544480. https://doi.org/10.3389/fmicb.2020.544480

Mohammed NA, Ajah HA, Abdulbaqi NJ. Detection The Prevalence of Adhesins and Extracellular hydrolytic enzymes genes in Candida albicans Biofilm Formation. Iraq J Sci. 2017; 58(2C): 988-1000. https://doi.org/10.24996.ijs.2017.58.2C.3

Atriwal T, Azeem K, Husain FM, Hussain A, Khan MN, Alajmi MF, Abid M. Mechanistic understanding of Candida albicans biofilm formation and approaches for its inhibition. Front Microbiol. 2021; 12: 638609. https://doi.org/10.3389/fmicb.2021.638609

Mello VG, Escudeiro H, Weckwerth AC, Andrade MI, Fusaro AE, de Moraes EB, Ruiz LD, Baptista IM. Virulence factors and antifungal susceptibility in Candida species isolated from dermatomycosis patients. Mycopathologia. 2021; 186(1): 71-80. https://doi.org/10.1007/s11046-020-00509-x

Talapko J, Juzbašić M, Matijević T, Pustijanac E, Bekić S, Kotris I, et al. Candida albicans- the virulence factors and clinical manifestations of infection. J Fungi. 2021; 7(2): 79. https://doi.org/10.3390/jof7020079

Yang HP, Tsang PC, Pow EH, Lam OL, Tsang PW. Candida albicans Secreted Aspartic Protease 7 is Essential for Damage of Human Oral Epithelial Cells. J Bacteriol Mycol. 2021; 8(5): 1182.

Staniszewska M. Virulence factors in Candida species. Curr Protein Pept Sci. 2020; 21(3): 313-23. https://doi.org/10.2174/1389203720666190722152415

Vieira E, Cunha SC, Ferreira IM. Characterization of a potential bioactive food ingredient from inner cellular content of brewer’s spent yeast. Waste Biomass Valori. 2019; 10: 3235-3242.‏ https://doi.org/10.1007/s12649-018-0368-9

Ramos-Pardo A, Castro-Álvarez R, Quindós G, Eraso E, Sevillano E, Kaberdin VR. Assessing pH-dependent activities of virulence factors secreted by Candida albicans. Microbiologyopen. 2023; 12(1): e1342. https://doi.org/10.1002/mbo3.1342

Abeed FK, Alrubayae IM. Evaluation of virulence factors of clinical yeast isolates from nosocomial fungal infections with the determination of their antifungal susceptibility profile. Iran J Ichthyol. 2022; 15(9): 61-8.

Nouraei H, Pakshir K, ZareShahrabadi Z, Zomorodian K. High detection of virulence factors by Candida species isolated from bloodstream of patients with candidemia. Microb Pathog. 2020; 149: 104574. https://doi.org/10.1016/j.micpath.2020.104574

Linares CE, de Loreto ES, Silveira CP, Pozzatti P, Scheid LA, Santurio JM, et al. Enzymatic and hemolytic activities of Candida dubliniensis strains. Rev Inst Med Trop Sao Paulo. 2007; 49(4): 203-6. https://doi.org/10.1590/s0036-46652007000400001

Nouraei H, Pakshir K, ZareShahrabadi Z, Zomorodian K. High detection of virulence factors by Candida species isolated from bloodstream of patients with candidemia. Microb Pathog. 2020; 149: 104574. https://doi.org/10.1016/j.micpath.2020.104574

Salvin SB. Hemolysin from the yeast-like phases of some pathogenic fungi. Proc Soc Exp Biol Med. 1951; 76(4): 852-4. https://doi.org/10.3181/00379727-76-18653

Lee S, Kichik Rodriguez N, Hepworth O, Richardson J, Naglik J. In Vitro Biophysical Characterization of Candidalysin: A Fungal Peptide Toxin. In In Vitro Biophysical Characterization of Candidalysin: A Fungal Peptide Toxin. SpringerLink. 2022. p. 163-176. https://doi.org/10.1007/978-1-0716-2549-1_12

Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun. 1994; 62(11): 5154-6. https://doi.org/10.1128/iai.62.11.5154-5156.1994

Richardson JP, Brown R, Kichik N, Lee S, Priest E, Mogavero S, et al. Candidalysins Is a New Family of Cytolytic Fungal Peptide Toxins. ASM J mBio. 2022; 13(1): e0351021. https://doi.org/10.1128/mbio.03510-21

Mogavero S, Sauer FM, Brunke S, Allert S, Schulz D, Wisgott S, et al. Candidalysin delivery to the invasion pocket is critical for host epithelial damage induced by Candida albicans. Cell Microbiol. 2021; 23(10): e13378. https://doi.org/10.1111/cmi.13378

Roy U, Kornitzer D. Heme-iron acquisition in fungi. Curr Opin Microbiol. 2019 Dec 1; 52: 77-83. https://doi.org/10.1016/j.mib.2019.05.006

Richardson JP, Mogavero S, Moyes DL, Blagojevic M, Krüger T, Verma AH, et al. Processing of Candida albicans Ece1p Is Critical for Candidalysin Maturation and Fungal Virulence. ASM J mBio. 2018; 9(1): e02178-17. https://doi.org/10.1128/mBio.02178-17

Richardson JP, Willems HME, Moyes DL, Shoaie S, Barker KS, Tan SL, et al. Candidalysin Drives Epithelial Signaling, Neutrophil Recruitment, and Immunopathology at the Vaginal Mucosa. Infect Immun. 2018; 86(2): e00645-17. https://doi.org/10.1128/IAI.00645-17

Macias-Paz IU, Pérez-Hernández S, Tavera-Tapia A, Luna-Arias JP, Guerra-Cárdenas JE, Reyna-Beltrán E. Candida albicans the main opportunistic pathogenic fungus in humans. Rev Argent Microbiol. 2022; https://doi.org/10.1016/j.ram.2022.08.003

Bain JM, Louw J, Lewis LE, Okai B, Walls CA, Ballou ER, et al. Candida albicans hypha formation and mannan masking of β-glucan inhibit macrophage phagosome maturation. ASM J mBio. 2014; 5(6):e01874. https://doi.org/10.1128/mBio.01874-14

Willems HME, Lowes DJ, Barker KS, Palmer GE, Peters BM. Comparative Analysis of the Capacity of the Candida Species To Elicit Vaginal Immunopathology. Infect Immun. 2018; 86(12): e00527-18. https://doi.org/10.1128/IAI.00527-18